The present invention relates to use of dihydrocelastrol (represented by a formula I) in preparation of drugs for prevention or treatment of hematological tumor diseases. According to the present invention, the dihydrocelastrol can significantly prevent and treat multiple myeloma, lymphoma and other tumors, has substantially-reduced toxic effect compared to celastrol, and has good clinical application prospects. The formula I is defined in the specification.